The CEO of Japan's largest pharmaceutical company admits to inappropriate expressions,' but denies any tampering with research data.
from WSJ.com: US Business http://ift.tt/1jM3gZ5
via IFTTT
from WSJ.com: US Business http://ift.tt/1jM3gZ5
via IFTTT
No comments:
Post a Comment